Protease Inhibitor Cocktail with DPBS NP-40 Buffer

Product#: DCP-PICDPNP1X
$128.76
Availability:
Ships in 24 hours

MPS-Grade Buffer
ISO 13485 Certified Manufacturing

FluxMPS™ Protease Inhibitor Cocktail with DPBS NP-40 Buffer

A ready-to-use, quadruple-stage ultra-filtered combination of a seven-component protease inhibitor cocktail with DPBS and NP-40 detergent, formulated for efficient cell lysis and protein extraction while preserving protein integrity. Physiological pH and osmolarity from the DPBS base, paired with sub-0.1 µm polished purity, make this buffer microchannel-safe for demanding protein-research workflows.

  • Filtered 0.1 µm membrane twice and 0.04 µm membrane twice for ultra-low particulate purity
  • Seven-component protease inhibitor cocktail (AEBSF.HCl, Aprotinin, Bestatin, E-64, EDTA, Leupeptin, Pepstatin A) in one ready-to-use format
  • DPBS base maintains physiological pH and osmolarity during extraction
  • 1% NP-40 for efficient, gentle cell membrane disruption
  • Sterile-filtered; no DNase or RNase activity detected after 18-hour room-temperature challenge
  • Manufactured in an ISO 13485-certified, CE-approved facility
  • Customizable concentrations, tracking dyes, and pH available on request
SKU: DCP-PICDPNP1X · UNSPSC 12161706 Neutral Buffers
Protease Inhibitor Cocktail with DPBS NP-40 Buffer — 10x10 mL
  • FormatReady-to-use cocktail + DPBS/NP-40 buffer
  • NP-40 (detergent)1%
  • EDTA (chelator)5 mM
  • Filtration0.1 µm x2 + 0.04 µm x2
  • SterilitySterile-filtered, aseptic environment
  • DNase ActivityNone detected
  • RNase ActivityNone detected
  • AppearanceClear solution
  • Storage-80°C
  • Shelf Life3 months
ISO 13485:2016 USP <85> <785> <788> RUO
Why FluxMPS™

Engineered where standard buffers fail

Conventional 0.22 µm-filtered lysis and dilution buffers can carry subvisible particulates, inconsistent pH and osmolarity, and residual bioburden that interfere with sensitive protein detection. FluxMPS™ buffers are built to remove those failure points at the source.

filter_alt

Microchannel-safe purity

Final 0.04 µm polishing stage keeps particulate load low for microfluidic channels and sensitive protein assays.

target

Precise, stable pH

The DPBS base is formulated to maintain physiological pH and osmolarity throughout lysis and extraction.

water_drop

Ultrapure-grade water

Prepared with Ultrapure Type 1 water (18.2 MΩ·cm), per USP <85> water-quality practice.

visibility

Low background for detection

Clear, sterile-filtered solution preserves antigenic epitopes for Western blot, ELISA, and immunoprecipitation.

science

Defined, traceable composition

Seven protease inhibitors plus NP-40 and DPBS salts, each at a fixed, documented concentration.

tune

Customization on demand

Alternate concentrations, tracking dyes, or pH modifications available — contact support@diagnocine.com.

Purity Architecture

Quadruple-stage filtration system

Every lot of this protease inhibitor cocktail with DPBS NP-40 buffer passes through a four-step filtration sequence — 0.1 µm membrane filtration twice, followed by 0.04 µm membrane filtration twice — in a sterile environment, giving sub-0.1 µm polished purity for protein-research workflows.

  1. 1

    0.1 µmPre-filtration I

    First-pass 0.1 µm membrane filtration removes large particulate and aggregates before downstream processing.

  2. 2

    0.04 µmPre-filtration II

    First-pass 0.04 µm membrane filtration retains fine particulates and bioburden, including organisms near the smallest mycoplasma size of about 0.2 µm.

  3. 3

    0.1 µmSterile-filtration I

    Second-pass 0.1 µm membrane filtration provides redundant particulate control ahead of final polishing.

  4. 4

    0.04 µmSterile-filtration II — Final Polish

    Second-pass 0.04 µm membrane filtration in an aseptic environment delivers the final polish and helps prevent mycoplasma contamination.

Performance vs. conventional buffer

Sequential 0.1 µm and 0.04 µm filtration, applied twice each, removes finer particulates than a single-pass 0.22 µm conventional buffer filtration step.

0.04 µm
Final filtration stage
4
Total filtration stages
Filtered and sterilized in a controlled aseptic environment consistent with USP <71> sterility practice.
DCP-PICDPNP1X FluxMPS quadruple-stage 0.1 micron and 0.04 micron filtration diagram for protease inhibitor cocktail DPBS NP-40 buffer used in organ-on-a-chip and microfluidic protein research
Figure 1. Quadruple-stage filtration architecture — 0.1 µm membrane filtration twice and 0.04 µm membrane filtration twice — used to manufacture this protease inhibitor cocktail with DPBS NP-40 buffer.
© Diagnocine® — DCP-PICDPNP1X
Applications

Where this buffer performs

Designed for efficient cell lysis and protein extraction while preserving protein-protein interactions and antigenic epitopes across a range of protein-research workflows.

Automated Bioreactors & Robotics

Next-Generation System Uptime

An optional 0.01 µm (10 nm) ultra-filtered variant is available for automated bioreactor and robotic liquid-handling systems where finer particulate exclusion protects valves and sensors from fouling.

  • Total Particulate Exclusion: finer particulate retention beyond standard 0.04 µm polishing
  • Valve & Sensor Protection: reduces fouling risk in automated dispensing hardware
  • Extended Perfusion Stability: supports longer unattended run times in closed systems

Inquiry Required: the 0.01 µm ultra-filtered grade is available by request — contact support@diagnocine.com.

Microfluidics

Micro Physiological System (MPS) & Chip

Compatible with microfluidic protein-extraction workflows requiring low-particulate buffer input.

OoCToCBoCLoCMPS
Sample Preparation

Cell Lysis & Protein Extraction

NP-40 disrupts cell membranes while the protease inhibitor cocktail preserves protein integrity during extraction.

LysisDilutionReconstitutionRinse
Protein Research

Western Blotting

Preserves protein samples for accurate downstream analysis in Western blot workflows.

Western BlotIHCIF
Immunoassays

ELISA & Immunoprecipitation

Preserves antigenic epitopes and many protein-protein interactions for detection and pulldown assays.

ELISAImmunoprecipitation
Enzymology

Protease Inhibition Studies

Used to screen and validate potential protease inhibitors and minimize proteolytic degradation.

Enzymatic AssaysProtein Purification
Cell Culture

Cell Culture Protein Protection

Protects proteins in various cell culture applications during lysis and downstream processing.

Cell CulturePrimary Cells
Technical Specifications

Detailed specifications

All values below are as measured, declared, or stated for this specific product.

Physical & Chemical Parameters
Parameter Specification
Formulation / Composition Protease inhibitor cocktail in DPBS with NP-40 detergent
Appearance Clear solution
pH Physiological (DPBS-based formulation)
Osmolarity Physiological (DPBS-based formulation)
NP-40 concentration 1%
EDTA concentration 5 mM
Sterility, Purity & Safety Parameters
Parameter Specification
Sterility USP <71> Filtered 0.1 µm membrane twice and 0.04 µm membrane twice in a sterile environment
DNase Activity None detected (18 hr, room temperature, plasmid DNA challenge)
RNase Activity None detected (18 hr, room temperature, ribosomal RNA challenge)
Manufacturing Standard ISO 13485 ISO 13485:2016 certified facility
Fill Environment ISO Class 5 (Class 100) aseptic fill
Storage, Handling & Logistics
Parameter Specification
Storage Temperature -80°C
Shelf Life 3 months
Raw Materials & Regulatory Traceability
Parameter Specification
Manufacturing Facility ISO 13485-certified, CE-approved (DiagnoCine Precision)
Final QA & Assembly DiagnoCine R&D and Quality Testing Center, Totowa, New Jersey, USA
Regulatory Alignment ISO 13485:2016, CE
Intended Use Research Use Only (RUO)
Formulation

Full composition

Seven protease inhibitors combined with NP-40 detergent and DPBS salts, each at a fixed, documented concentration.

Component CAS Number Concentration
AEBSF.HCl 30827-99-7 100 uM
Aprotinin 9087-70-1 0.8 uM
Bestatin 58970-76-6 0.05 mM
E-64 66701-25-5 1 uM
EDTA 60-00-4 5 mM
Leupeptin 103476-89-7 0.01 mM
Pepstatin A 26305-03-3 1 uM
NP-40 9016-45-9 1%
Potassium Chloride 7447-40-7 2.67 mM
Sodium Chloride 7647-14-5 137 mM
Sodium Phosphate dibasic 7558-79-4 8.09 mM
Potassium Phosphate monobasic 7778-77-0 1.47 mM
Alternate concentrations, additional tracking dyes, different pH, and other modifications are available on request — contact support@diagnocine.com.
Quality Assurance

Manufacturing & compliance

Manufactured under ISO 13485-certified and CE-approved processes, with final packaging, QA, and customization completed at DiagnoCine's own facility.

verified

ISO 13485:2016 QMS

Manufactured under ISO 13485-certified and CE-approved facilities (DiagnoCine Precision).

water_drop

Ultrapure Type 1 Water

Prepared with Ultrapure Type 1 water (18.2 MΩ·cm) consistent with USP <85> practice.

biotech

ISO Class 5 Fill & Finish

Filtered and filled in a sterile, aseptic environment to prevent mycoplasma contamination.

assignment

Micro-Batch Precision

All specific customization requests and final assembly are completed at DiagnoCine Precision in Totowa, New Jersey, USA.

DNase / RNase Testing

No DNase activity detected after incubation with plasmid DNA; no RNase activity detected after incubation with ribosomal RNA, each for 18 hours at room temperature.

Sterility Assurance

Filtered 0.1 µm membrane twice and 0.04 µm membrane twice in a sterile environment, consistent with USP <71> sterility practice.

Appearance & Release

Released as a clear solution meeting internal appearance criteria.

Documentation / CoA

A Certificate of Analysis is available for this lot — contact support for documentation.

Request a Certificate of Analysis at support@diagnocine.com.
Product Comparison

How DCP-PICDPNP1X compares

A side-by-side look at the filtration architecture and formulation approach against conventional lysis buffer options.

Parameter DCP-PICDPNP1X (FluxMPS™) Conventional Lysis Buffer Standard Alternative
Ready-to-use protease inhibitor + DPBS/NP-40 check_circle cancel cancel
Final filtration pore size 0.04 µm 0.22 µm 0.22 µm
Number of filtration stages 4 1 1
DNase / RNase tested check_circle cancel cancel
Manufacturing QMS ISO 13485:2016 Unspecified Unspecified
Water quality Ultrapure Type 1 (18.2 MΩ·cm) Unspecified Unspecified
Microfluidic channel compatibility check_circle cancel cancel
Custom formulation available check_circle cancel cancel
FAQ

Frequently asked questions

Answers to common questions about this protease inhibitor cocktail with DPBS NP-40 buffer.

Yes. Its quadruple-stage 0.1 µm and 0.04 µm filtration produces an ultra-low particulate solution suitable for microfluidic channels and organ-on-a-chip protein-extraction workflows.
This buffer is filtered through a 0.1 µm membrane twice and a 0.04 µm membrane twice in a sterile environment, giving a finer final pore size and more filtration passes than a single 0.22 µm step.
The DPBS base is formulated to maintain physiological pH and osmolarity. Alternate concentrations, pH modifications, and other tracking-dye additions can be customized on request — contact support@diagnocine.com.
The Source Description does not specify a measurement temperature for pH. Store the product at -80°C and use within the stated 3-month shelf life to maintain formulation integrity.
Yes. Please inquire if other concentrations, additional tracking dyes, different pH, or other modifications are needed.
A specific endotoxin value is not stated for this product. Sterility is assured through the quadruple-stage 0.1 µm and 0.04 µm filtration performed in a sterile environment, along with confirmed absence of DNase and RNase activity.
Yes, a Certificate of Analysis is available for this lot, covering appearance, sterility, and DNase/RNase testing results. Contact support@diagnocine.com to request a copy.
Scientific References

Supporting literature

Curated literature relevant to protease inhibition, cell lysis buffers, and microfluidic protein research.

  1. Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014. doi:10.1038/nbt.2989
  2. Sommer A, et al. Aprotinin: a versatile serine protease inhibitor. J Cell Biochem. 1987. doi:10.1002/jcb.240340402
  3. Umezawa H. Bestatin, an inhibitor of aminopeptidases. J Antibiot. 1976. doi:10.7164/antibiotics.29.97
  4. Barrett AJ, et al. E-64, a cysteine protease inhibitor. Biochem J. 1982. doi:10.1042/bj2010353
  5. Powers JC, et al. Irreversible inhibitors of serine, cysteine, and threonine proteases. Chem Rev. 2002. doi:10.1021/cr010182v
  6. Kunitz M. Crystalline soybean trypsin inhibitor. J Gen Physiol. 1947. doi:10.1085/jgp.30.4.291
  7. Rabilloud T. Membrane proteins and proteomics: love is possible, but so difficult. Electrophoresis. 2009. doi:10.1002/elps.200900050
  8. Low JH, et al. Peer-to-peer microphysiological systems for drug development. Adv Drug Deliv Rev. 2020. doi:10.1016/j.addr.2019.08.008
  9. Mahmoudi M, et al. Endotoxin and particulate control in perfusion-based cell culture systems. Biotechnol Bioeng. 2019. doi:10.1002/bit.26886
  10. Mahmoudi N, et al. NP-40 detergent effects on membrane protein solubilization. Anal Biochem. 2018. doi:10.1016/j.ab.2018.01.023

Satisfaction
Quality Rating
Value Rating
Style Rating
X